{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-003886","form_type":"8-K","ticker":"DOC","cik":"0000765880","company_name":"HEALTHPEAK PROPERTIES, INC.","filed_at":"2024-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.885480+00:00","generated_at":"2026-06-06T06:05:25.038835+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Healthpeak Q4 FFO as Adj $0.46/share; Same-store NOI +3.6%; new $236M lab JV","bullets":["Q4 net income $0.13/share, Nareit FFO $0.48, FFO as Adj $0.46, AFFO $0.36; FY23 net income $0.56, Nareit FFO $1.79, FFO as Adj $1.78, AFFO $1.53.","Total Same-Store Portfolio Cash NOI growth 3.6% Q4, 4.8% full-year.","Q4 lease executions 1.1M sq ft (743K outpatient, 312K lab); YTD 2024 lab leases 58K sq ft + 115K under LOI.","Entered $236M JV selling 65% interest in Callan Ridge lab campus in San Diego (Jan 2024).","Net Debt to Adjusted EBITDAre 5.2x; issued $750M senior unsecured notes at ~5.35% blend."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-003886","json":"https://secwatch.observer/filing/0001628280-24-003886.json","markdown":"https://secwatch.observer/filing/0001628280-24-003886.md","text":"https://secwatch.observer/filing/0001628280-24-003886.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/765880/000162828024003886/0001628280-24-003886-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/765880/000162828024003886/peak-20240208.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T06:05:25.038835+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"24ebe48851d2e8408bcc9bbeb6db99570922cee2","claim":"HEALTHPEAK PROPERTIES, INC. reported Three Months Ended December 31, 2023 results: net income $70,787 thousand, EPS $0.13.","evidence_excerpt":"FOURTH QUARTER 2023 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS – Net income of $0.13 per share, Nareit FFO of $0.48 per share, FFO as Adjusted of $0.46 per share, AFFO of $0.36 per share, and Total Same-Store Portfolio Cash (Adjusted) NOI growth of 3.6% – Fourth quarter new and renewal lease executions totaled 1.1 million square feet: ▪ Outpatient Medical new and renewal lease executions totaled 743,000 square feet ▪ Lab new and renewal lease executions totaled 312,000 square feet ▪ Year-to-date 2024 Lab lease executions of 58,000 square feet with an additional 115,000 square feet under signed LOI – Received entitlements for an additional 1.3 million square feet of lab development at the Vantage campus in South San Francisco – Commenced two on-campus outpatient developments in our HCA Healthcare (\"HCA\") development program – Entered into a new $236 million joint venture through the sale","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/765880/000162828024003886/0001628280-24-003886-index.htm","confidence":0.92,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Three Months Ended December 31, 2023"},{"label":"Net income","value":"$70,787 thousand"},{"label":"EPS","value":"$0.13"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"6d5c4dd5b4b6cba996f005ccf6bb23c3043f1a87","claim":"HEALTHPEAK PROPERTIES, INC. reported Year Ended December 31, 2023 results: net income $304,284 thousand, EPS $0.56.","evidence_excerpt":"int venture through the sale of a 65% interest in the Callan Ridge lab campus in the Torrey Pines submarket of San Diego in January 2024 – Net Debt to Adjusted EBITDAre was 5.2x for the quarter ended December 31, 2023 FULL-YEAR 2023 HIGHLIGHTS – Net income of $0.56 per share, Nareit FFO of $1.79 per share, FFO as Adjusted of $1.78 per share, AFFO of $1.53 per share, and Total Same-Store Portfolio Cash (Adjusted) NOI growth of 4.8% – Portfolio leasing summary: ▪ Full-year outpatient lease executions totaled 4.1 million square feet, with +4% cash releasing spreads on renewals ▪ Full-year lab lease executions totaled 985,000 square feet, with +23% cash releasing spreads on renewals – Development highlights: ▪ 2023 completions and new starts: ▪ Nexus on Grand: Delivered the fully leased, 148,000 square foot, $161 million lab building in South San Francisco ▪ Vantage: Delivered the fully leas","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/765880/000162828024003886/0001628280-24-003886-index.htm","confidence":0.92,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Year Ended December 31, 2023"},{"label":"Net income","value":"$304,284 thousand"},{"label":"EPS","value":"$0.56"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}